Action SRDX SURMODICS, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Communiqués Surmodics, Inc.

Actions

SRDX

US8688731004

Marché Fermé - Nasdaq
Autres places de cotation
 22:00:00 16/07/2024 		Varia. 5j. Varia. 1 janv.
42,11 USD +0,33 % Graphique intraday de Surmodics, Inc. -0,31 % +15,85 %
10/06 Surmodics signe un accord d'achat groupé avec Premier MT
10/06 Surmodics, Inc. reçoit un accord sur les produits de thrombectomie avec Premier, Inc. CI

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
STOCKHOLDER ALERT: The M&A Class Action Firm Investigates Merger of Surmodics, Inc. - SRDX
PR
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HCP, SRDX, CALB, FFNW on Behalf of Shareholders
PR
Kuehn Law Encourages, FFNW, HCP, CALB, and SRDX Investors to Contact Law Firm
PR
Surmodics Awarded Thrombectomy Products Agreement with Premier, Inc.
BU
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Surmodics, Inc.
PR
Shareholder Alert: Ademi LLP investigates whether Surmodics, Inc. has obtained a Fair Price for its Public Shareholders
PR
SRDX Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Surmodics to GTCR
AQ
SRDX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Surmodics, Inc. Is Fair to Shareholders
BU
Surmodics Enters into Definitive Agreement to be Acquired by GTCR for $43.00 Per Share in Cash, Representing an Approximate Equity Value of $627 Million
BU
SurModics: Fiscal Q2 Earnings Snapshot
AQ
Surmodics Reports Second Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance
BU
Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1
AQ
Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1
BU
Surmodics to Participate in Upcoming Investor Conferences in March and April
BU
Surmodics Reports First Quarter of Fiscal Year 2024 Financial Results, Updates Fiscal Year 2024 Financial Guidance
AQ
SurModics: Fiscal Q1 Earnings Snapshot
AQ
Surmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance
BU
Surmodics Announces Successful Early Clinical Use of Pounce LP Thrombectomy System, Designed to Address a Critical, Unmet Need by Facilitating Removal of Thrombi and Emboli below the Knee
AQ
Surmodics Announces Successful Early Clinical Use of Pounce™ LP (Low Profile) Thrombectomy System, Designed to Address a Critical, Unmet Need by Facilitating Removal of Thrombi and Emboli Below the Knee
BU
Surmodics to Report First Quarter of Fiscal 2024 Financial Results on February 1
BU
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action SRDX
  4. Actualités Surmodics, Inc.
  5. Communiqués